FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
7 letters match. Newest first.
-
DrugsMONQ, LLC
MONQ sold unapproved inhalation essential oil products with claims to treat opioid addiction and withdrawal, FDA and FTC said.
High risk -
DrugsEagle Energy USA, Inc.
FDA warned Eagle Energy USA that its inhalable Caffeine Pen products are unapproved new drugs with safety concerns.
High risk -
DrugsVitaStik, Inc.
FDA warned VitaStik that its oral inhalation sticks are unapproved new drugs marketed with claims to treat asthma, anxiety, sleep and other conditions.
High risk -
DrugsVitaCig, Inc.
FDA warned VitaCig that its flavored inhalers and capsules are unapproved new drugs sold with disease-treatment claims on its website.
High risk -
DrugsNV Nutrition, LLC
FDA warned NV Nutrition that its inhalable vaporizer and diffuser products are drugs sold without FDA approval and promoted with disease claims.
High risk -
DrugsVitamin Vape, Inc.
FDA says Vitamin Vape sold B12 VitaminVape as a drug without FDA approval and made drug claims online.
High risk -
DrugsEvolved Ayurvedic Discoveries, Inc./BioCBDPlus
FDA warned BioCBDPlus that its CBD topicals and vape are unapproved new drugs sold with disease and COVID-19 claims.
High risk